QazCovid-in (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "QazCovid-in" in English language version.

refsWebsite

Global rank English rank

4inform.kz

4,199^th place

6,577^th place

3astanatimes.com

8,381^st place

5,769^th place

2clinicaltrials.gov

5,225^th place

4,062^nd place

2nih.gov

4^th place

1eurasianet.org

3,649^th place

2,889^th place

1time.kz

low place

1caspiannews.com

low place

1sng.today

low place

1aa.com.tr

754^th place

1,313^th place

1tengrinews.kz

3,391^st place

9,511^th place

1doi.org

2^nd place

1informburo.kz

9,706^th place

low place

aa.com.tr

Kussainova M (10 April 2021). "Kazakhstan's COVID-19 vaccine to be bottled in Turkey". www.aa.com.tr. Retrieved 12 April 2021.

astanatimes.com

Yergaliyeva A (20 December 2020). "Kazakhstan Begins Vaccinating 3,000 Volunteers With Self-Made QazCovid-in". The Astana Times. Retrieved 2 March 2021.
Arystanbek A. "Kazakh Biosafety Research Institute Begins Clinical Trials of Another Vaccine Against COVID-19". The Astana Times.
Satubaldina A (5 October 2021). "Kazakhstan to Supply Its QazVac COVID-19 Vaccine to Other Countries Next Year". The Astana Times.

caspiannews.com

Batyrov A (25 April 2021). "Kazakhstan Launches Production of First Homegrown Vaccine, 'QazVac'". caspiannews.com. Retrieved 26 April 2021.

clinicaltrials.gov

Clinical trial number NCT04691908 for "Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine" at ClinicalTrials.gov
Clinical trial number NCT04530357 for "Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine" at ClinicalTrials.gov

doi.org

Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, et al. (September 2021). "Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan". eClinicalMedicine. 39: 101078. doi:10.1016/j.eclinm.2021.101078. PMC 8363482. PMID 34414368.

eurasianet.org

Kumenov A (1 April 2021). "Kazakhstan: Officials under fire over vaccination failures". Eurasianet. Retrieved 11 April 2021.

inform.kz

Tatyana K (31 March 2021). "Vaccination with homegrown QazVac vaccine likely to start in late April". www.inform.kz. Retrieved 11 April 2021.^{[permanent dead link]}
Tatyana K (26 April 2021). "Health Minister Alexei Tsoi to be one of the first to get homegrown QazCovid-in vaccine". www.inform.kz. Retrieved 26 April 2021.
Tatyana K (21 April 2021). "Healthcare Ministry comments on production of QazVac vaccine". www.inform.kz. Retrieved 22 April 2021.
Tatyana K (9 April 2021). "3rd stage of clinical trials of QazCovid-in vaccine to be 50% complete by Apr 15". www.inform.kz. Retrieved 11 April 2021.

informburo.kz

Mauletbay S (9 April 2021). "Казахстанскую вакцину QazVac будут разливать в Турции" [Kazakhstan vaccine QazVac will be bottled in Turkey]. informburo.kz (in Russian). Retrieved 12 April 2021.

nih.gov

ncbi.nlm.nih.gov

Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, et al. (September 2021). "Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan". eClinicalMedicine. 39: 101078. doi:10.1016/j.eclinm.2021.101078. PMC 8363482. PMID 34414368.

pubmed.ncbi.nlm.nih.gov

Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, et al. (September 2021). "Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan". eClinicalMedicine. 39: 101078. doi:10.1016/j.eclinm.2021.101078. PMC 8363482. PMID 34414368.

sng.today

"К концу апреля в Казахстане будет выпущено 50000 доз собственной вакцины" [By the end of April, 50,000 doses of its own vaccine will be released in Kazakhstan]. SNG.TODAY (in Russian). Retrieved 12 April 2021.

tengrinews.kz

Ondiris A (9 April 2021). "Как правильно применять казахстанскую вакцину QazVac, рассказал ученый" [How to properly apply the Kazakh vaccine QazVac]. Главные новости Казахстана - Tengrinews.kz (in Russian). Retrieved 11 April 2021.

time.kz

Akulova O, Gani T (9 April 2021). "QazVac готова и уже на подходе" [QazVac is ready and on the way]. Время [Time] (in Russian). Retrieved 11 April 2021.